🚨 New article spotlight! Taking on the CLIA lab director role is more than regulatory—it’s leadership with real clinical impact. For early-career pathologists, it's a crash course in EQ, conflict resolution, strategic thinking, and team trust. 🧠 Leadership in lab medicine =

Straight from our editor-in-chief! Words of wisdom about balloon cell in steatohepatitis!

Here's another novel use for AI: For triaging of lymph node core biopsies & resections ! ❗ AI performance equivalent to that of a hematopathologist ⭐ Validated on core biopsies and resections ⭐ Could significantly reduce time taken for specialist referral Read more here :

Exciting news! 🎉 JCP, in collaboration with the Association of Clinical Pathologists, is launching the ACP-JCP Early Career Prize for the Best Original #Research Paper! 🏆 The first prize will be awarded in 2025, and research papers published online in JCP throughout 2024 are

Carcinoma arising in microglandular adenosis (MGACA) is a rare triple-negative breast cancer subtype, often basal-like immune-suppressed (BLIS). Frequent mutations: TP53🧬, BRCA1🔍 & MYC📈.

📊 The Area Under the Curve (AUC) is a single number that shows how well a model can tell categories apart. It combines sensitivity (finding true positives) and specificity (avoiding false positives) into one overall score. A perfect model has an AUC of 1.0—no missed diagnoses,

In machine learning, we make models smarter by ‘messing up’ the training data: random brightness changes, color shifts, rotations, even blur. This trick is called data augmentation. It forces the AI to focus on what really matters, not superficial distractions. #AI #Pathology

📈 New study from the Swedish National Prostate Cancer Register (2000–2020) reveals a drift in how high-grade prostate cancers are scored on biopsy. 🔬 Shift toward heterogeneous Gleason patterns (3+5, 4+5) and away from uniform high-grade scores (4+4, 5+5) may reflect evolving

🚨 New article spotlight! Taking on the CLIA lab director role is more than regulatory—it’s leadership with real clinical impact. For early-career pathologists, it's a crash course in EQ, conflict resolution, strategic thinking, and team trust. 🧠 Leadership in lab medicine =

❓ What are the patterns of HER2 expression in lung adenocarcinomas ? ❓ Do HER2 positive tumours show ERBB2 mutations ? ❓ Is HER2 testing in cytology samples good enough ? Watch this video to find out more and read all about it right here bit.ly/3S0Tcml

🚨 Launch Alert! We’re proud to debut a new series evaluating clinical-grade Machine learning tools for cancer diagnosis, starting with prostate adenocarcinoma. Dr. Thaker breaks down diagnosis with the IBEX algorithm: the wins, the flaws, and a granular dive into methods,

📈 New study from the Swedish National Prostate Cancer Register (2000–2020) reveals a drift in how high-grade prostate cancers are scored on biopsy. 🔬 Shift toward heterogeneous Gleason patterns (3+5, 4+5) and away from uniform high-grade scores (4+4, 5+5) may reflect evolving

We need to start considering the emissions associated with digital storage in pathology. Here’s a very rough estimate: 📦 70,000 cases/year 🖼️ 8 WSI slides per case (~1 GB each) ⏳ Stored for 20 years Here’s a good primer on data centre emissions and digital

Ever heard of 'Shaken biopsies' ? 🤔 Read about this novel way to obtain material for genomics ! Open access too 🎉 bit.ly/3S6zw0i

💡 Liquid biopsies to detect EGFR mutations in NSCLC - Does it work ? Find out! bit.ly/3F6C0Ji

🚨 New article spotlight! Taking on the CLIA lab director role is more than regulatory—it’s leadership with real clinical impact. For early-career pathologists, it's a crash course in EQ, conflict resolution, strategic thinking, and team trust. 🧠 Leadership in lab medicine =

Straight from our editor-in-chief! Words of wisdom about balloon cell in steatohepatitis!